Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RLAYRelay Therapeutics, Inc.

Nasdaq · CIK 0001812364
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts236

Identity from submissions API

NameRelay Therapeutics, Inc.
CIK0001812364
TickersRLAY
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-370-8837
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
60 HAMPSHIRE STREET
CAMBRIDGE
MA
02139
MA
Mailing address
60 HAMPSHIRE STREET
CAMBRIDGE
MA
02139
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

562 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 4 0001193125-26-470277 7219
2026-11-20 4 4 0001193125-26-470275 5373
2026-11-20 4 4 0001193125-26-470274 5414
2026-11-18 144 xsl144X01/primary_doc.xml 0001950047-26-011307 001-39385 261571043 33 6268
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-052668 005-92097 261563739 34 10408
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000749 005-92097 261556538 34 7470
2026-11-04 10-Q 10-Q 0001193125-26-447294 001-39385 261522455 34 8653059 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001193125-26-447250 001-39385 261522270 34 402686 1 1
2026-10-30 4 4 0001193125-26-441713 5136
2026-10-30 4 4 0001193125-26-441694 5044
2026-10-30 4 4 0001193125-26-441690 5086
2026-10-08 4 4 0001193125-26-418096 7219
2026-10-08 4 4 0001193125-26-418094 7387
2026-10-07 144 xsl144X01/primary_doc.xml 0001950047-26-010107 001-39385 261447390 33 6217
2026-10-06 144 xsl144X01/primary_doc.xml 0001950047-26-010071 001-39385 261444318 33 7065
2026-09-09 4 4 0001193125-26-386473 5373
2026-09-09 4 4 0001193125-26-386464 5415
2026-09-09 4 4 0001193125-26-386455 7219
2026-08-28 4 4 0001193125-26-374645 5465
2026-08-28 4 4 0001493152-26-040513 9607
2026-08-26 144 xsl144X01/primary_doc.xml 0001950047-26-008711 001-39385 261323130 33 5449
2026-08-25 144 xsl144X01/primary_doc.xml 0001493152-26-040137 001-39385 261317273 33 4653
2026-08-18 4 4 0001193125-26-355502 7219
2026-08-18 4 4 0001193125-26-355493 5415
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000036 005-92097 261281651 34 14942
2026-08-10 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-342308 005-92097 261258236 34 10737
2026-08-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002255 005-92097 261252475 34 11689
2026-08-06 424B5 424B5 0001193125-26-338292 333-281308 261249927 33 524883 1 1
2026-08-06 10-Q 10-Q 0001193125-26-338056 001-39385 261249300 34 7856417 1 1
2026-08-06 8-K 8-K 1.01,2.02,9.01 0001193125-26-338013 001-39385 261249110 34 442458 1 1
2026-08-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002113 005-92097 261247191 34 11530
2026-08-04 144 xsl144X01/primary_doc.xml 0001950047-26-007601 001-39385 261238782 33 6768
2026-07-31 144 xsl144X01/primary_doc.xml 0001950047-26-007457 001-39385 261228441 33 6072
2026-07-30 4 4 0001193125-26-326144 5083
2026-07-30 4 4 0001193125-26-326142 5133
2026-07-30 4 4 0001193125-26-326137 5042
2026-07-21 144 xsl144X01/primary_doc.xml 0001950047-26-007243 001-39385 261190337 33 5376
2026-07-20 144 xsl144X01/primary_doc.xml 0001950047-26-007212 001-39385 261186714 33 4680
2026-07-08 4 4 0001193125-26-298688 5373
2026-07-08 4 4 0001193125-26-298681 9145
2026-07-08 4 4 0001193125-26-298679 5415
2026-07-07 144 xsl144X01/primary_doc.xml 0001950047-26-006935 001-39385 261159722 33 4801
2026-07-02 4 4 0001193125-26-294528 7434
2026-06-30 144 xsl144X01/primary_doc.xml 0001950047-26-006653 001-39385 261140997 33 5429
2026-06-24 4 4 0001193125-26-281061 22249
2026-06-24 4 4 0001193125-26-281059 9141
2026-06-22 144 xsl144X01/primary_doc.xml 0001950047-26-006399 001-39385 261107884 33 6153
2026-06-22 144 xsl144X01/primary_doc.xml 0001950047-26-006398 001-39385 261107878 33 8922
2026-06-10 4 4 0001193125-26-265913 5439
2026-06-10 4 4 0001193125-26-265911 5423
2026-06-10 4 4 0001193125-26-265907 5420
2026-06-10 4 4 0001193125-26-265906 5439
2026-06-10 4 4 0001193125-26-265905 5385
2026-06-10 4 4 0001193125-26-265908 5398
2026-06-10 4 4 0001193125-26-265904 5423
2026-06-09 8-K 8-K 5.03,5.07,9.01 0001193125-26-263873 001-39385 261076603 34 201502 1 1
2026-05-21 8-K 8-K 1.01,9.01 0001193125-26-234862 001-39385 261009780 34 401515 1 1
2026-05-21 424B5 424B5 0001193125-26-234428 333-281308 261008561 33 778608 1 1
2026-05-19 424B5 424B5 0001193125-26-231113 333-281308 261000309 33 637929
2026-05-19 8-K 8-K 7.01,8.01,9.01 0001193125-26-229770 001-39385 26996000 34 12775410 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003486 005-92097 26988135 34 11086
2026-05-14 4 4 0001193125-26-224545 5414
2026-05-14 144 xsl144X01/primary_doc.xml 0001950047-26-004516 001-39385 26979405 33 7784
2026-05-05 10-Q 10-Q 0001193125-26-206454 001-39385 26943401 34 7170384 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001193125-26-206398 001-39385 26943163 34 317679 1 1
2026-04-30 4 4 0001193125-26-197419 5082
2026-04-30 4 4 0001193125-26-197415 5133
2026-04-30 4 4 0001193125-26-197395 5042
2026-04-28 ARS ARS 0001193125-26-187091 001-39385 26907967 34 1498385
2026-04-28 DEFA14A DEFA14A 0001193125-26-187039 001-39385 26907804 34 4217754
2026-04-28 DEF 14A DEF 14A 0001193125-26-186929 001-39385 26907578 34 16304949 1 1
2026-04-27 8-K 8-K 7.01,8.01,9.01 0001193125-26-179404 001-39385 26896896 34 10880118 1 1
2026-04-16 PRE 14A PRE 14A 0001193125-26-158969 001-39385 26867550 34 16304712 1 1
2026-04-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-152824 005-92097 26857769 34 479226
2026-04-09 4 4 0001193125-26-150044 11303
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002139 005-92097 26803169 34 7142
2026-03-19 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-115967 005-92097 26774298 34 417166
2026-03-16 8-K 8-K 7.01,8.01,9.01 0001193125-26-107312 001-39385 26754596 34 221492 1 1
2026-03-11 4 4 0001193125-26-102270 5277
2026-03-11 8-K 8-K 5.03,9.01 0001193125-26-102178 001-39385 26743527 34 349836 1 1
2026-03-09 144 xsl144X01/primary_doc.xml 0001950047-26-002370 001-39385 26735593 33 6135
2026-02-26 S-8 S-8 0001193125-26-076900 333-293799 26689461 33 365098 1 1
2026-02-26 10-K 10-K 0001193125-26-076739 001-39385 26688331 34 18321617 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001193125-26-076617 001-39385 26688082 34 386719 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-26-001221 005-92097 26642877 34 18778
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-26-001220 005-92097 26642822 34 18778
2026-02-03 8-K 8-K 7.01,8.01,9.01 0001193125-26-034422 001-39385 26590137 34 192224 1 1
2026-01-29 4 4 0001193125-26-029415 6776
2026-01-29 4 4 0001193125-26-029412 8911
2026-01-29 4 4 0001193125-26-029403 6818
2026-01-15 4 4 0001193125-26-014111 5265
2026-01-15 4 4 0001193125-26-014110 5358
2026-01-15 4 4 0001193125-26-014109 5295
2026-01-15 4 4 0001193125-26-014106 5307
2026-01-07 4 4 0001193125-26-006328 9248
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000024 005-92097 251487098 34 14855
2025-11-06 4 4 0001193125-25-269790 5206
2025-11-06 4 4 0001193125-25-269769 5231
2025-11-06 3 3 0001193125-25-269711 13243
2025-11-06 3 3 0001193125-25-269707 13268
2025-11-06 10-Q 10-Q 0001193125-25-269601 001-39385 251458566 34 9541605 1 1
2025-11-06 8-K 8-K 2.02,5.02,7.01,9.01 0001193125-25-269536 001-39385 251458411 34 371576 1 1
2025-11-04 4 4 0001193125-25-264700 17111
2025-10-30 4 4 0001193125-25-258595 17001
2025-10-30 4 4 0001193125-25-258574 15030
2025-10-30 4 4 0001193125-25-258557 15006
2025-10-29 144 xsl144X01/primary_doc.xml 0001950047-25-008255 001-39385 251430234 33 9468
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000014 005-92097 251220845 34 15287
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003691 005-92097 251220564 34 12135
2025-08-07 10-Q 10-Q 0000950170-25-105054 001-39385 251194314 34 9727880 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-105022 001-39385 251194088 34 365514 1 1
2025-07-30 4 4 0000950170-25-100367 6864
2025-07-30 4 4 0000950170-25-100366 6814
2025-07-30 4 4 0000950170-25-100365 6772
2025-07-30 4 4 0000950170-25-100364 6739
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000992 005-92097 251160468 34 6182
2025-07-10 4 4 0000950170-25-095093 8754
2025-07-01 4 4 0000950170-25-092315 5137
2025-07-01 4 4 0000950170-25-092305 7027
2025-06-11 4 4 0000950170-25-084838 5242
2025-06-11 3 3 0000950170-25-084836 13238
2025-06-11 8-K 8-K 5.02,9.01 0001193125-25-139146 001-39385 251040144 34 157868 1 1
2025-06-06 4 4 0000950170-25-083314 5285
2025-06-06 4 4 0000950170-25-083312 5304
2025-06-06 4 4 0000950170-25-083311 5250
2025-06-06 4 4 0000950170-25-083310 5260
2025-06-06 4 4 0000950170-25-083306 5288
2025-06-06 4 4 0000950170-25-083305 5286
2025-06-06 8-K 8-K 5.07 0001193125-25-137162 001-39385 251031890 34 142138 1 1
2025-06-04 8-K 8-K 1.01,1.02 0001193125-25-134908 001-39385 251023279 34 136097 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-010853 005-92097 25952607 34 16578
2025-05-05 10-Q 10-Q 0000950170-25-063553 001-39385 25913136 34 7564680 1 1
2025-05-05 8-K 8-K 2.02,9.01 0000950170-25-063539 001-39385 25913018 34 320106 1 1
2025-04-30 4 4 0000950170-25-061367 6914
2025-04-30 4 4 0000950170-25-061366 9923
2025-04-30 4 4 0000950170-25-061365 6821
2025-04-30 4 4 0000950170-25-061364 6788
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000558 005-92097 25892127 34 6227
2025-04-29 144 xsl144X01/primary_doc.xml 0001950047-25-002594 001-39385 25886987 33 13828
2025-04-28 144 xsl144X01/primary_doc.xml 0001950047-25-002580 001-39385 25880157 33 12753
2025-04-24 4 4 0000950170-25-057996 8808
2025-04-23 ARS ARS 0000950170-25-057381 001-39385 25861640 34 2302614
2025-04-23 DEFA14A DEFA14A 0000950170-25-057350 001-39385 25861537 34 2184722
2025-04-23 DEF 14A DEF 14A 0000950170-25-057333 001-39385 25861383 34 10739576 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000649 005-92097 25844568 34 11036
2025-03-31 4 4 0000950170-25-047762 4954
2025-03-31 4 4 0000950170-25-047743 5045
2025-03-31 4 4 0000950170-25-047725 6608
2025-03-31 4 4 0000950170-25-047717 4919
2025-03-27 144 xsl144X01/primary_doc.xml 0001950047-25-002214 001-39385 25779219 33 11883
2025-03-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-001532 005-92097 25758028 34 16365
2025-02-26 S-8 S-8 0000950170-25-027812 333-285281 25670637 33 363891 1 1
2025-02-26 10-K 10-K 0000950170-25-027756 001-39385 25670253 34 17862897 1 1
2025-02-26 8-K 8-K 2.02,9.01 0000950170-25-027733 001-39385 25670092 34 379338 1 1
2025-02-13 4 4 0000950170-25-020272 10602
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001239 005-92097 25592244 34 12061
2025-01-30 4 4 0000950170-25-011335 10579
2025-01-30 4 4 0000950170-25-011327 11720
2025-01-30 4 4 0000950170-25-011319 10486
2025-01-30 4 4 0000950170-25-011311 8584
2025-01-29 144 xsl144X01/primary_doc.xml 0001950047-25-000469 001-39385 25569315 33 12406
2025-01-28 144 xsl144X01/primary_doc.xml 0001950047-25-000463 001-39385 25565040 33 11503
2025-01-23 4 4 0000950170-25-008451 12004
2025-01-23 144 xsl144X01/primary_doc.xml 0001950047-25-000394 001-39385 25550088 33 8371
2025-01-22 144 xsl144X01/primary_doc.xml 0001950047-25-000375 001-39385 25545926 33 6921
2025-01-21 144 xsl144X01/primary_doc.xml 0001950047-25-000342 001-39385 25542570 33 5617
2025-01-14 4 4 0000950170-25-005568 5415
2025-01-14 4 4 0000950170-25-005567 5289
2025-01-14 4 4 0000950170-25-005566 5352
2025-01-14 4 4 0000950170-25-005565 5322
2025-01-14 4 4 0000950170-25-005564 5364
2025-01-13 8-K 8-K 7.01,9.01 0000950170-25-004586 001-39385 25524963 34 13239928 1 1
2025-01-06 4 4 0000950170-25-002500 9168
2025-01-06 144 xsl144X01/primary_doc.xml 0001950047-25-000115 001-39385 25511079 33 7564
2025-01-03 144 xsl144X01/primary_doc.xml 0001950047-25-000085 001-39385 25506238 33 6873
2024-12-31 4 4 0000950170-24-141599 4930
2024-12-31 4 4 0000950170-24-141598 4965
2024-12-31 4 4 0000950170-24-141597 7142
2024-12-31 4 4 0000950170-24-141596 5056
2024-12-27 144 xsl144X01/primary_doc.xml 0001950047-24-010088 001-39385 241585712 33 9811
2024-12-18 4 4 0000950170-24-137960 7220
2024-12-16 144 xsl144X01/primary_doc.xml 0001950047-24-009851 001-39385 241552073 33 4892
2024-12-11 8-K 8-K 7.01,8.01,9.01 0000950170-24-135207 001-39385 241540119 34 17091292 1 1
2024-11-14 SC 13G/A rlay13gasep24.txt 0000080255-24-001461 005-92097 34 6707
2024-11-06 10-Q 10-Q 0000950170-24-122332 001-39385 241431154 34 7444786 1 1
2024-11-06 8-K 8-K 2.02,9.01 0000950170-24-122297 001-39385 241431004 34 345450 1 1
2024-10-30 4 4 0000950170-24-118985 5058
2024-10-30 4 4 0000950170-24-118982 8068
2024-10-30 4 4 0000950170-24-118981 4965
2024-10-30 4 4 0000950170-24-118974 4932
2024-10-29 144 xsl144X01/primary_doc.xml 0001950047-24-007919 001-39385 241405667 33 7570
2024-10-28 144 xsl144X01/primary_doc.xml 0001950047-24-007889 001-39385 241400896 33 10505
2024-10-01 4 4 0000950170-24-110811 5057
2024-10-01 4 4 0000950170-24-110810 7143
2024-10-01 4 4 0000950170-24-110808 4966
2024-10-01 4 4 0000950170-24-110804 4931
2024-09-27 144 xsl144X01/primary_doc.xml 0001950047-24-007433 001-39385 241335272 33 9707
2024-09-11 8-K 8-K 1.01,8.01,9.01 0001193125-24-217296 001-39385 241293121 34 447536 1 1
2024-09-11 424B5 424B5 0001193125-24-217294 333-281308 241293104 33 1523386 1 1
2024-09-09 424B5 424B5 0001193125-24-215956 333-281308 241287743 33 1362334
2024-09-09 8-K 8-K 7.01,8.01,9.01 0000950170-24-104557 001-39385 241285876 34 17056232 1 1
2024-08-06 S-3ASR S-3ASR 0001193125-24-194962 333-281308 241180584 33 1053367 1 1
2024-08-06 10-Q 10-Q 0000950170-24-091837 001-39385 241179456 34 7056293 1 1
2024-08-06 8-K 8-K 2.02,9.01 0000950170-24-091802 001-39385 241179300 34 350908 1 1
2024-07-31 4 4 0000950170-24-088815 7141
2024-07-31 4 4 0000950170-24-088813 11135
2024-07-31 4 4 0000950170-24-088812 4962
2024-07-31 4 4 0000950170-24-088811 4929
2024-07-31 144 xsl144X01/primary_doc.xml 0001950047-24-005694 001-39385 241161941 33 22552
2024-07-30 144 xsl144X01/primary_doc.xml 0001950047-24-005673 001-39385 241157738 33 21860
2024-07-29 4 4 0000950170-24-087435 16441
2024-07-29 144 xsl144X01/primary_doc.xml 0001950047-24-005652 001-39385 241152818 33 11464
2024-07-29 144 xsl144X01/primary_doc.xml 0001950047-24-005651 001-39385 241152689 33 19890
2024-07-26 144 xsl144X01/primary_doc.xml 0001950047-24-005629 001-39385 241147697 33 5540
2024-07-25 144 xsl144X01/primary_doc.xml 0001950047-24-005597 001-39385 241142053 33 4850
2024-07-16 8-K 8-K 1.02,9.01 0000950170-24-083928 001-39385 241119819 34 149459 1 1
2024-07-01 4 4 0000950170-24-079693 7108
2024-07-01 4 4 0000950170-24-079692 4966
2024-07-01 4 4 0000950170-24-079691 7023
2024-07-01 4 4 0000950170-24-079689 7122
2024-07-01 4 4 0000950170-24-079684 4952
2024-06-27 144 xsl144X01/primary_doc.xml 0001950047-24-005052 001-39385 241079519 33 9012
2024-06-12 4 4 0000950170-24-072426 6957
2024-06-06 8-K 8-K 7.01,8.01,9.01 0000950170-24-069674 001-39385 241023871 34 34115041 1 1
2024-06-05 4 4 0000950170-24-069560 5349
2024-06-05 4 4 0000950170-24-069559 5325
2024-06-05 4 4 0000950170-24-069558 5347
2024-06-05 4 4 0000950170-24-069557 5321
2024-06-05 4 4 0000950170-24-069556 5311
2024-06-05 4 4 0000950170-24-069555 5365
2024-06-05 4 4 0000950170-24-069554 5346
2024-06-05 4 4 0000950170-24-069553 9165
2024-06-05 144 xsl144X01/primary_doc.xml 0001950047-24-004423 001-39385 241022131 33 7557
2024-06-04 144 xsl144X01/primary_doc.xml 0001950047-24-004380 001-39385 241017989 33 6865
2024-06-03 8-K 8-K 5.07 0000950170-24-067952 001-39385 241013574 34 165925 1 1
2024-05-02 10-Q 10-Q 0000950170-24-052135 001-39385 24908479 34 6568284 1 1
2024-05-02 8-K 8-K 2.02,9.01 0000950170-24-052110 001-39385 24908303 34 280172 1 1
2024-04-29 4 4 0000950170-24-050152 5055
2024-04-29 4 4 0000950170-24-050151 4929
2024-04-29 4 4 0000950170-24-050147 5004
2024-04-29 4 4 0000950170-24-050146 4962
2024-04-23 ARS ARS 0000950170-24-046910 001-39385 24864986 34 6907855
2024-04-23 DEFA14A DEFA14A 0000950170-24-046897 001-39385 24864903 34 3712833
2024-04-23 DEF 14A DEF 14A 0000950170-24-046883 001-39385 24864829 34 13147566 1 1
2024-03-29 4 4 0000950170-24-038658 5001
2024-03-29 4 4 0000950170-24-038656 4961
2024-03-29 4 4 0000950170-24-038654 5059
2024-03-29 4 4 0000950170-24-038655 4926
2024-02-22 S-8 S-8 0000950170-24-018826 333-277278 24665421 33 202739
2024-02-22 10-K 10-K 0000950170-24-018797 001-39385 24665020 34 16490243 1 1
2024-02-22 8-K 8-K 2.02,9.01 0000950170-24-018763 001-39385 24664804 34 354933 1 1
2024-02-14 SC 13G/A d10823826_13g-a.htm 0000919574-24-001483 005-92097 24638697 34 130457
2024-02-14 SC 13G rlay13gdec23.txt 0000080255-24-000757 005-92097 34 6510
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021821 005-92097 24629446 34 13077
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002474 5272
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002472 5218
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002470 5197
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002468 5185
2024-01-26 SC 13G/A us75943r1023_012624.txt 0001086364-24-004367 005-92097 24565869 34 13667
2024-01-23 SC 13G/A Relay_Th_Inc.txt 0000093751-24-000081 005-92097 24550682 34 8526
2024-01-18 4 FORM 4 SUBMISSION 0001209191-24-001847 5180
2024-01-18 4 FORM 4 SUBMISSION 0001209191-24-001843 7088
2024-01-18 4 FORM 4 SUBMISSION 0001209191-24-001840 5147
2024-01-18 4 FORM 4 SUBMISSION 0001209191-24-001837 5104
2024-01-18 4 FORM 4 SUBMISSION 0001209191-24-001835 5072
2024-01-10 424B7 424B7 0001193125-24-005687 333-258768 24525089 33 459352
2024-01-10 D xslFormDX01/primary_doc.xml 06b 0001802806-24-000003 021-502011 24525061 33 15432
2024-01-08 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0000950170-24-002682 001-39385 24518293 34 16807311 1 1
2023-12-29 4 FORM 4 SUBMISSION 0001209191-23-060000 5267
2023-12-29 4 FORM 4 SUBMISSION 0001209191-23-059998 5234
2023-12-29 4 FORM 4 SUBMISSION 0001209191-23-059996 5194
2023-12-29 4 FORM 4 SUBMISSION 0001209191-23-059991 5159
2023-11-16 424B7 424B7 0001193125-23-278809 333-258768 231414798 33 494509
2023-11-02 10-Q 10-Q 0000950170-23-058237 001-39385 231372553 34 8506193 1 1
2023-11-02 8-K 8-K 2.02,9.01 0000950170-23-058199 001-39385 231372367 34 389453 1 1
2023-11-01 4 FORM 4 SUBMISSION 0001209191-23-054027 5186
2023-11-01 4 FORM 4 SUBMISSION 0001209191-23-054024 5153
2023-11-01 4 FORM 4 SUBMISSION 0001209191-23-054020 5111
2023-11-01 4 FORM 4 SUBMISSION 0001209191-23-054016 5078
2023-10-12 8-K 8-K 7.01,8.01,9.01 0000950170-23-053109 001-39385 231322861 34 17335860 1 1
2023-10-02 SC 13G d10823826_13-g.htm 0000919574-23-005444 005-92097 231299800 34 105254
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050874 7112
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050869 7547
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050866 7620
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050863 5152
2023-09-29 4 FORM 4 SUBMISSION 0001209191-23-050857 5077
2023-08-08 10-Q 10-Q 0000950170-23-039874 001-39385 231151795 34 9160066 1 1
2023-08-08 8-K 8-K 2.02,7.01,9.01 0000950170-23-039822 001-39385 231151484 34 31834672 1 1
2023-07-31 4 FORM 4 SUBMISSION 0001209191-23-043850 5184
2023-07-31 4 FORM 4 SUBMISSION 0001209191-23-043843 5151
2023-07-31 4 FORM 4 SUBMISSION 0001209191-23-043838 5109
2023-07-31 4 FORM 4 SUBMISSION 0001209191-23-043834 5076
2023-07-10 SC 13G/A filing.txt 0000315066-23-002356 005-92097 231078541 34 8187
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040063 5181
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040061 5148
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040059 5108
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040054 5073
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033444 5488
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033442 5453
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033438 5463
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033436 5491
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033434 5489
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033432 5467
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033428 5507
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033423 5098
2023-06-01 4/A FORM 4/A SUBMISSION 0001209191-23-033421 5701
2023-06-01 4/A FORM 4/A SUBMISSION 0001209191-23-033419 5668
2023-06-01 4/A FORM 4/A SUBMISSION 0001209191-23-033416 5626
2023-06-01 4/A FORM 4/A SUBMISSION 0001209191-23-033410 5593
2023-05-31 8-K 8-K 5.07 0000950170-23-025321 001-39385 23981023 34 197725 1 1
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032515 4778
2023-05-25 8-K 8-K 7.01,9.01 0000950170-23-024290 001-39385 23961888 34 226434 1 1
2023-05-04 10-Q 10-Q 0000950170-23-017894 001-39385 23889047 34 7985278 1 1
2023-05-04 8-K 8-K 2.02,9.01 0000950170-23-017857 001-39385 23888792 34 386197 1 1
2023-05-01 4 FORM 4 SUBMISSION 0001209191-23-026280 5183
2023-05-01 4 FORM 4 SUBMISSION 0001209191-23-026277 5150
2023-05-01 4 FORM 4 SUBMISSION 0001209191-23-026275 5109
2023-05-01 4 FORM 4 SUBMISSION 0001209191-23-026271 5075
2023-04-21 ARS ARS 0000950170-23-013836 001-39385 23836386 34 14384838
2023-04-21 DEFA14A DEFA14A 0000950170-23-013833 001-39385 23836310 34 3019439
2023-04-21 DEF 14A DEF 14A 0000950170-23-013832 001-39385 23836287 34 6275618 1 1
2023-04-18 8-K 8-K 7.01,8.01,9.01 0000950170-23-013199 001-39385 23825825 34 23281364 1 1
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021423 5181
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021420 5148
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021417 5108
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021414 5073
2023-02-23 S-8 S-8 0000950170-23-004157 333-269959 23660478 33 281939
2023-02-23 10-K 10-K 0000950170-23-004123 001-39385 23659889 34 21165157 1 1
2023-02-23 8-K 8-K 2.02,9.01 0000950170-23-004106 001-39385 23659748 34 470195 1 1
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-008072 23021
2023-02-09 SC 13G/A filing.txt 0000315066-23-001995 005-92097 23605004 34 8184
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016833 005-92097 23604113 34 12996
2023-02-03 SC 13G Relay_Therapeutics_Inc.txt 0000093751-23-000177 005-92097 23585433 34 8489
2023-02-01 SC 13G/A us75943r1023_013123.txt 0001306550-23-005889 005-92097 23573914 34 13411
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005706 5153
2023-01-31 5 FORM 5 SUBMISSION 0001209191-23-005702 7716
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005700 5120
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005696 5079
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005687 5045
2023-01-19 4 FORM 4 SUBMISSION 0001209191-23-004135 10145
2023-01-19 4 FORM 4 SUBMISSION 0001209191-23-004127 27590
2023-01-19 4 FORM 4 SUBMISSION 0001209191-23-004125 10155
2023-01-19 4 FORM 4 SUBMISSION 0001209191-23-004123 10076
2023-01-19 4 FORM 4 SUBMISSION 0001209191-23-004122 10115
2023-01-13 4 FORM 4 SUBMISSION 0001209191-23-003272 4831
2023-01-09 8-K 8-K 7.01,9.01 0000950170-23-000426 001-39385 23516508 34 26211402 1 1
2023-01-05 3 FORM 3 SUBMISSION 0001209191-23-002073 13642
2022-12-28 4 FORM 4 SUBMISSION 0001209191-22-062827 5118
2022-12-28 4 FORM 4 SUBMISSION 0001209191-22-062818 5078
2022-12-28 4 FORM 4 SUBMISSION 0001209191-22-062815 5043
2022-11-10 4 FORM 4 SUBMISSION 0001209191-22-056427 22222
2022-11-03 10-Q 10-Q 0000950170-22-021892 001-39385 221358289 34 10307670 1 1
2022-11-03 8-K 8-K 2.02,9.01 0000950170-22-021868 001-39385 221358101 34 458175 1 1
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055121 5111
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055119 5120
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055116 11540
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055112 5044
2022-10-13 4 FORM 4 SUBMISSION 0001209191-22-053597 23037
2022-10-11 SC 13G/A filing.txt 0000315066-22-001795 005-92097 221302554 34 8008
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052221 9536
2022-09-29 4 FORM 4 SUBMISSION 0001209191-22-051549 5111
2022-09-29 4 FORM 4 SUBMISSION 0001209191-22-051544 5119
2022-09-29 4 FORM 4 SUBMISSION 0001209191-22-051542 5079
2022-09-29 4 FORM 4 SUBMISSION 0001209191-22-051539 5044
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050182 23038
2022-09-15 8-K 8-K 1.01,8.01,9.01 0000950170-22-018514 001-39385 221244461 34 807142 1 1
2022-09-13 424B5 424B5 0001193125-22-243800 333-258768 221241530 33 599178
2022-09-12 424B5 424B5 0001193125-22-242425 333-258768 221237385 33 576524
2022-09-12 8-K 8-K 7.01,8.01,9.01 0000950170-22-018311 001-39385 221237309 34 3139292 1 1
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049246 4710
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049244 9092
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049242 9016
2022-09-08 8-K 8-K 7.01,9.01 0000950170-22-018205 001-39385 221232481 34 211802 1 1
2022-09-02 4 FORM 4 SUBMISSION 0001209191-22-048561 9011
2022-09-01 4 FORM 4 SUBMISSION 0001209191-22-048391 9536
2022-09-01 424B7 424B7 0001193125-22-236502 333-258768 221221019 33 485208
2022-08-25 4 FORM 4 SUBMISSION 0001209191-22-047560 9016
2022-08-08 4 FORM 4 SUBMISSION 0001209191-22-044859 9011
2022-08-04 10-Q 10-Q 0000950170-22-014809 001-39385 221137267 34 7990858 1 1
2022-08-04 8-K 8-K 2.02,9.01 0000950170-22-014798 001-39385 221137190 34 441941 1 1
2022-07-29 4 FORM 4 SUBMISSION 0001209191-22-043543 5108
2022-07-29 4 FORM 4 SUBMISSION 0001209191-22-043541 5116
2022-07-29 4 FORM 4 SUBMISSION 0001209191-22-043536 5075
2022-07-29 4 FORM 4 SUBMISSION 0001209191-22-043534 5041
2022-07-27 4 FORM 4 SUBMISSION 0000899243-22-026903 5372
2022-07-27 3 FORM 3 SUBMISSION 0001209191-22-043270 7446
2022-07-27 8-K 8-K 5.02 0000950170-22-013150 001-39385 221108884 34 168906 1 1
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041639 7081
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041628 9011
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039662 5106
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039659 5114
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039656 5039
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039654 11052
2022-06-27 8-K 8-K 7.01,8.01,9.01 0000950170-22-012133 001-39385 221041534 34 4440299 1 1
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032685 5459
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032682 5421
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032679 5456
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032676 5475
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032674 5435
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032671 5457

Latest XBRL company facts

One latest value per concept from companyfacts (236 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 220.96M 2026-10-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
dei EntityPublicFloat Entity Public Float USD 585.50M 2025-06-30 2025 FY 10-K 2026-02-26 0001193125-26-076739
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt pure 0.081 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-186929
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.96M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-186929
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.60M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-186929
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 119.92 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-186929
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 9.12M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-186929
ecd PeoTotalCompAmt PeoTotalCompAmt USD 4.65M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-186929
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 20.36 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-186929
ffd NetFeeAmt NetFeeAmt USD 29,412.27 2026-08-05 424B5 2026-08-06 0001193125-26-338292
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 212.98M 2026-08-05 424B5 2026-08-06 0001193125-26-338292
ffd TtlFeeAmt TtlFeeAmt USD 29,412.27 2026-08-05 424B5 2026-08-06 0001193125-26-338292
ffd TtlOfferingAmt TtlOfferingAmt USD 212.98M 2026-08-05 424B5 2026-08-06 0001193125-26-338292
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-05 424B5 2026-08-06 0001193125-26-338292
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-05 424B5 2026-08-06 0001193125-26-338292
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 306,000 2022-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018797
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 45.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 21.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -5.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 3.08B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 10.12M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs USD 20.29M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 62.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 26.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AreaOfLand Area of Land sqft 46,631 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056229
us-gaap Assets Assets USD 901.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AssetsCurrent Assets, Current USD 864.85M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 5.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 729.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 724.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset USD -4.59M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007873
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -1.83M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-02 0000950170-24-052135
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 159,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 124.18M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 125.38M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 40.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 8.03M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 450.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 219.50M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 219.50M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap CommonStockValue Common Stock, Value, Issued USD 212,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 92,000 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056229
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -244.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 4.91M 2022-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018797
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 248,000 2021-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 715.51M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 61.99M 2020-07-20 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 37.21M 2020-07-08 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 724.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 5.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD -3.81M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 724.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 5.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions DebtSecurity 97 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 1.12M 2020-06-30 2020 Q2 10-Q 2020-08-27 0001193125-20-233120
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 10.82M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 1.12M 2020-06-30 2020 Q2 10-Q 2020-08-27 0001193125-20-233120
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 7.68M 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 1.73M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 491.34M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 10.82M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 235.13M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 923.90M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 625.60M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 57,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 96.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 15.66M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 480.52M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap Depreciation Depreciation USD 1.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.19 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.28 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-04 0000950170-22-014809
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.19 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.191 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.067 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027756
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.031 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 132.74M 2021-06-30 2021 Q2 10-Q 2021-08-12 0001564590-21-043999
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 186.43M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -4.59M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007873
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 662,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 4.75M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 56,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 101,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD -2.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 38.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -363.87M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 52.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -58.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 266,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 10.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 5,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 8.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -993,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122332
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 28.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -306,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 18.71M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122332
us-gaap IncreaseDecreaseInCommodityContractAssetsAndLiabilities Increase (Decrease) in Commodity Contract Assets and Liabilities USD -4.91M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -22,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018797
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 961,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -7.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap InterestIncomeOther Interest Income, Other USD 20.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap Investments Investments USD 724.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 37.21M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 15.96M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.98M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 4.50M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.38M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 4.25M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.13M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 12.79M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 1.70M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056229
us-gaap Liabilities Liabilities USD 82.70M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 901.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 2.33M 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap LiabilitiesCurrent Liabilities, Current USD 59.15M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 466.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -257.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -169.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -238.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -363.87M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OperatingExpenses Operating Expenses USD 263.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -259.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OperatingLeaseCost Operating Lease, Cost USD 4.02M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 24.42M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.49M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 23.54M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OperatingLeasePayments Operating Lease, Payments USD 4.88M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 30.31M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.104 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap OtherAssets Other Assets USD 22,000 2020-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap OtherAssetsCurrent Other Assets, Current USD 7.53M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax USD -2.69M 2022-04-01 2022-06-30 2022 Q2 10-Q 2022-08-04 0000950170-22-014809
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -6.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax USD 74,000 2021-07-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056229
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD -6.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OtherExpenses Other Expenses USD 53,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-05 0001193125-26-206454
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 15.00M 2021-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 3,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017894
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 20.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 2.51M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056229
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 25.30M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018797
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 643.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD -177.79M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 519.83M 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 337.27M 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 212.64M 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap PreferredStockValueOutstanding Preferred Stock, Value, Outstanding USD 0 2020-09-30 2020 Q3 10-Q 2020-11-12 0001193125-20-291681
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 12.75M 2022-06-30 2022 Q2 10-Q 2022-08-04 0000950170-22-014809
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 8.68M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 425.29M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.86M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021892
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 4.99M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap ProceedsFromSaleAndMaturityOfOtherInvestments Proceeds from Sale and Maturity of Other Investments USD 385.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 20,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 1.69M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 23.27M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 582,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 30.62M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027601
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 224.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 123.00M 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap RestrictedCash Restricted Cash USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 70 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-105054
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.25B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 3.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap Revenues Revenues USD 3.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 819,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 23.00M 2020-07-20 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 20 2020-07-20 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 29.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 4.60M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018797
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 7.96 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 9.62M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.776 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.735 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.018 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.004 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 9.77M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056229
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 79.63M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.15M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 4.49 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 210,781 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value USD/shares 20,369 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-27 0001193125-20-233120
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.90M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 30.14 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 5.55M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 266.05M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 7.70M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.99 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.09 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.91 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 10.9 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 819.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap StockIssued1 Stock Issued USD 62.99M 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 61.99M 2020-07-01 2020-07-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 297,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 62.99M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018797
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 715.57M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 901,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 30.28M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018797
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4.42M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD -177.79M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001978
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 537.78M 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015518
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -455,000 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001193125-20-291681
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076739
us-gaap VariableInterestEntityInitialConsolidationGainOrLoss Variable Interest Entity, Initial Consolidation, Gain (Loss) USD -11.86M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018797
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 112.23M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004123
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 108.47M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-04 0000950170-22-014809
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 200.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447294

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →